We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-2 of 2

FDA Regulatory and Compliance Monthly Recap June 2018
  • Loeb & Loeb LLP
  • USA
  • June 10 2018

In line with the HHS blueprint to lower drug prices and link payments for drugs to their value, the FDA finalized guidance to provide drug makers with